Saga Investments LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Saga Investments LLC
Changed world, new priorities and ways of working? Senior medtech CEOs put their finger on how altered attitudes and new expectations from staff, especially the younger entrants into corporate life, are influencing management styles, now and in the future.
ResMed’s planned buy-out of Germany health care software company Medifox is expected to strengthen its position with out-of-hospital providers outside of the US and strengthen its position as a worldwide leader in health care software solutions.
Already owner of about 60% of the troubled antibiotic firm, Innoviva agrees to pay $2.20 per share for all outstanding stock in Entasis. Roche, KaliVir partner on oncolytic virus therapies.
Philips’ revenues contraction in the first quarter of 2022 was less than feared and its order book remains impressive, but challenges presented by the recall program and generic post-COVID factors for the year ahead remain substantial.
- Other Names / Subsidiaries
- deCODE genetics ehf